Market revenue in 2023 | USD 32.4 million |
Market revenue in 2030 | USD 55.3 million |
Growth rate | 7.9% (CAGR from 2023 to 2030) |
Largest segment | Cardiac |
Fastest growing segment | Dermatology |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Cardiac, Dermatology, Nasal |
Key market players worldwide | Medtronic PLC, Becton Dickinson & Co, Edwards Lifesciences Corp, LivaNova PLC, Smiths Group PLC, Boston Scientific Corp |
Cardiac was the largest segment with a revenue share of 46.6% in 2023. Horizon Databook has segmented the Asia Pacific cannula market based on cardiac, dermatology, nasal covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is expected to grow at a higher CAGR over the forecast period owing to presence of a large patient pool, high proportion of the elderly suffering from chronic lifestyle diseases such as diabetes & cardiovascular diseases, and favorable government policies to transform healthcare practices in respective countries, especially in rural belts. Increasing prevalence of cardiovascular diseases and diabetes is expected to propel the market growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account